resveratrol has been researched along with Takayasu Arteritis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, M; Ren, T; Shi, G; Xu, Q | 1 |
1 trial(s) available for resveratrol and Takayasu Arteritis
| Article | Year |
|---|---|
Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arteritis: A randomized double-blind and placebo-controlled trial.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Humans; Male; Middle Aged; Resveratrol; Stilbenes; Takayasu Arteritis; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2017 |